III. OPEN GOVERNMENT STATUTES
Generally, the FDA's approach to data disclosure has been that no public disclosure of information will take place until (and unless) a drug is approved. [13] Indeed, the agency will not even acknowledge that an IND or an NDA has been filed, although companies filing with the Securities and Exchange Commission report such information and often ensure that positive findings from their studies receive media coverage. For those drugs that are evaluated by FDA advisory committees, there is an additional, brief window in which the NDA is formally acknowledged and the data supporting the application are disclosed.
The two statutes that have provided the greatest access to pharmaceutical data are the Federal Advisory Committee Act (FACA) 14 and the Freedom of Information Act (FOIA). [15] FACA ensures that advisory committees are subject to transparency requirements such as advance notice of upcoming meetings, opportunities for public attendance and input, and the preparation of transcripts. [16] FOIA requires public disclosure, upon request by any individual, of agency documents that do not fall into one of nine specific exemptions from disclosure. [17]
In 2004, the FDA processed a total of 18,540 FOIA requests at a cost of $12.8 million. [18] By permitting the online posting of certain frequently requested documents, the Internet has eased the agency's workload somewhat. But the backlog has nevertheless continued to grow and stood at 16,671 pending requests at the end of 2004.
The agency processes requests in two tracks: simple and complex. The latter category applies to requests seeking a voluminous number of records or records from which the agency will want to redact information that falls under one of the FOIA exemptions. For 2004, the agency reported that eighty-nine percent of the requests it received were simple and usually processed in a median of twenty-five days. Eleven percent were considered complex and were processed in a median of 325 days. In no instance did the FDA expedite processing in response to a requester's assertion of "an exceptional need or urgency," [19] the standard for expediting.
BMSN!
Interpret this as you will: III. OPEN GOVERNMENT
Top 10 Most Recent News Articles
RTI's $14M Boost: A Game-Changer for Tech Innovators
Breaking Ground in Tech Deployment The march toward commercializing new tech can be a nightmare. Ask any innovator trying to leap from lab genius to market ready, and they'll tell you the pathway is paved with hurdles—especially in the rough-and-tumble world of energy and industrial tech. RTI International's latest $14 million move? That's a massive step in leveling the...
Continue Reading
Cannabis Industry Pushes for Robust Financial Services
Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...
Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay
The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...
Continue Reading
RealNex Navigator Upgrades Unveil Vast CRE Capabilities
The Dawn of a New Navigator for CRE RealNex is unleashing a storm of enhancements to its Navigator platform, shaking up the commercial real estate (CRE) scene. Their latest upgrades are setting a new precedent for how brokers use technology to sharpen their game, handle transactions, and strategize in a market that never sleeps. Diving Deep into the Latest Upgrades First...
Continue Reading
Midlife ADHD in Women: New Challenges and Solutions
ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...
Continue Reading
Deadline Looms for EquipmentShare Investors' Legal Action
Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....
Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026
Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...
Continue Reading
Maurices Strengthens Position with Key Refinancing Deal
Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...
Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun
Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...
Continue Reading
GBI Bio's New CEO Jesse McCool to Propel Growth
Jesse McCool stepping into GBI's CEO shoes is the kind of move that makes you sit up straight and take notice. Let me tell you, the biomanufacturing scene is buzzing with this appointment, and McCool's got his work cut out for him in leading GBI Biomanufacturing's shift towards commercial-scale operations while expanding their early-stage biotech portfolio. A Veteran in...
Continue ReadingTop 5 Most Recently Viewed Articles
Projected Clinical Trials Market Growth to USD 102.12 Billion
Overview of the Clinical Trials Market The global clinical trials market is expected to reach a significant value of USD 102.12 billion by 2031. This represents a strong compound annual growth rate (CAGR) of 8.7% from 2024 to 2031. The growth is largely due to urbanization and a growing middle class, which have resulted in more sedentary lifestyles. This lifestyle change...
Continue Reading
High Tide Inc. Achieves Record Revenue of $142.5 Million
High Tide Inc. Reports Strong Quarterly Results High Tide Inc., a leading cannabis retail brand, has announced remarkable first-quarter results, achieving record revenues of $142.5 million. This milestone represents an 11% growth compared to the same period last year, reflecting the company's strong market position and effective business strategies. Remarkable Growth in...
Continue Reading
Exciting Changes at Disney: New Leadership and Future Prospects
Disney's Leadership Transition: A New Era Begins Walt Disney Co has made a commendable decision in appointing James P. Gorman, the Executive Chairman of Morgan Stanley, as the new Chairman of the Board. This transition is set to occur on January 2, 2025, as he takes over from Mark G. Parker, who has dedicated nine years to the role. Understanding the Upcoming CEO Search...
Continue Reading
SK Telecom Joins MIT Consortium for Generative AI Advancements
SK Telecom Becomes Founding Member of MIT GenAI Impact Consortium SK Telecom (NYSE: SKM) recently joined the MIT GenAI Impact Consortium, marking a significant step in its exploration of generative AI technologies. This partnership aims to delve into the commercialization of AI advancements, involving close collaboration with MIT faculty and several global industry...
Continue Reading
SaverOne Partners with Global Construction Leader for Safety
SaverOne Signs Major Agreement for Fleet Safety Implementation 200 SaverOne systems to be installed for enhanced safety SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a pioneering technology firm dedicated to improving transportation safety, has embarked on a significant collaboration with a prominent multinational company in the construction sector. This agreement comes...
Continue Reading